This site is intended for healthcare professionals

Go to /pro/cpd-dashboard page

This podcast episode is worth 0.34 CPD credits. CPD Dashboard

Go to /account/subscription-details page

This podcast episode is worth 0.34 CPD credits. Upgrade to Pro

Ep 47 – Prescribing medicines associated with dependence: how can NICE guideline NG215 support our practice?

00:00
00:00

Posted 3 May 2022

Dr Peter Bagshaw, Dr Rob Hampton

In this episode, which has been recorded for Chronic Conditions Month 2022, Dr Peter Bagshaw (Clinical Lead in Dementia and Mental Health, South Glos CCG) and Dr Rob Hampton (Portfolio GP, Leicestershire) discuss the prescribing of medicines associated with dependence and approaches to their withdrawal. Is there a link between deprivation and long-term use of pain medications? What is the role of "sensitisation" in primary pain conditions? What are the particular challenges associated with benzodiazepine withdrawal? What alternatives should we be considering?

 

Note: Peter and Rob refer to the draft version of NICE guideline NG215, which was published in its final form shortly after the episode was recorded.
More information on Chronic Conditions month can be found here.
Resources discussed in the episode:
NICE. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215).
Faculty of Pain Medicine. Opioids Aware.
Somerset Emotional Wellbeing Podcast.
Flippin' Pain.
Versus Arthritis website.
Live Well with Pain.
Tame the Beast.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.